Anna J. Żaczek

2.4k total citations
86 papers, 1.6k citations indexed

About

Anna J. Żaczek is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Anna J. Żaczek has authored 86 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 40 papers in Cancer Research and 35 papers in Molecular Biology. Recurrent topics in Anna J. Żaczek's work include Cancer Cells and Metastasis (25 papers), Cancer Genomics and Diagnostics (20 papers) and Cancer-related molecular mechanisms research (12 papers). Anna J. Żaczek is often cited by papers focused on Cancer Cells and Metastasis (25 papers), Cancer Genomics and Diagnostics (20 papers) and Cancer-related molecular mechanisms research (12 papers). Anna J. Żaczek collaborates with scholars based in Poland, Germany and Sweden. Anna J. Żaczek's co-authors include Aleksandra Markiewicz, Magdalena Książkiewicz, Krzysztof Piotr Bielawski, Marzena Wełnicka-Jaśkiewicz, Jolanta Szade, Anna Supernat, Jarosław Skokowski, Burkhard Brandt, Wojciech Biernat and Barbara Seroczyńska and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Analytical Chemistry.

In The Last Decade

Anna J. Żaczek

84 papers receiving 1.6k citations

Peers

Anna J. Żaczek
Anna J. Żaczek
Citations per year, relative to Anna J. Żaczek Anna J. Żaczek (= 1×) peers Julia V. Burnier

Countries citing papers authored by Anna J. Żaczek

Since Specialization
Citations

This map shows the geographic impact of Anna J. Żaczek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna J. Żaczek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna J. Żaczek more than expected).

Fields of papers citing papers by Anna J. Żaczek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna J. Żaczek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna J. Żaczek. The network helps show where Anna J. Żaczek may publish in the future.

Co-authorship network of co-authors of Anna J. Żaczek

This figure shows the co-authorship network connecting the top 25 collaborators of Anna J. Żaczek. A scholar is included among the top collaborators of Anna J. Żaczek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna J. Żaczek. Anna J. Żaczek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Popęda, Marta, Adriana Mika, Tomasz Śledziński, et al.. (2024). Knock-out of CD73 delays the onset of HR-negative breast cancer by reprogramming lipid metabolism and is associated with increased tumor mutational burden. Molecular Metabolism. 89. 102035–102035. 4 indexed citations
2.
Richert, J R, Elżbieta Senkus, Sylwia Łapińska‐Szumczyk, et al.. (2024). Measurable morphological features of single circulating tumor cells in selected solid tumors—A pilot study. Cytometry Part A. 105(12). 883–892. 2 indexed citations
3.
Żaczek, Anna J., et al.. (2024). Isolation of Viable Epithelial and Mesenchymal Circulating Tumor Cells from Breast Cancer Patients. Methods in molecular biology. 2752. 43–52. 1 indexed citations
5.
Żaczek, Anna J., et al.. (2022). Detection and Characterization of Circulating Tumor Cells Using Imaging Flow Cytometry—A Perspective Study. Cancers. 14(17). 4178–4178. 25 indexed citations
6.
Grešner, Peter, et al.. (2022). Breast cancer circulating tumor cells with mesenchymal features—an unreachable target?. Cellular and Molecular Life Sciences. 79(2). 81–81. 12 indexed citations
8.
Bednarz‐Knoll, Natalia, Marta Popęda, Katarzyna Pogoda, et al.. (2021). Higher platelet counts correlate to tumour progression and can be induced by intratumoural stroma in non-metastatic breast carcinomas. British Journal of Cancer. 126(3). 464–471. 9 indexed citations
9.
Nastały, Paulina, Marta Popęda, Emanuele Martini, et al.. (2021). Low Tumor-to-Stroma Ratio Reflects Protective Role of Stroma against Prostate Cancer Progression. Journal of Personalized Medicine. 11(11). 1088–1088. 5 indexed citations
10.
Markiewicz, Aleksandra, Marta Popęda, Jolanta Szade, et al.. (2021). Activation of epithelial-mesenchymal transition process during breast cancer progression – the impact of molecular subtype and stromal composition. Acta Biochimica Polonica. 68(3). 385–392. 1 indexed citations
11.
Kunc, Michał, Marta Popęda, Anna Szałkowska, et al.. (2020). microRNA Expression Profile in Single Hormone Receptor-Positive Breast Cancers Is Mainly Dependent on HER2 Status—A Pilot Study. Diagnostics. 10(9). 617–617. 8 indexed citations
12.
Bieńkowski, Michał, Rafał Pęksa, Marta Popęda, et al.. (2019). Liquid biopsy for minimally invasive heart transplant monitoring: a pilot study. Journal of Clinical Pathology. 73(8). 507–510. 4 indexed citations
13.
Szade, Jolanta, Anna J. Żaczek, Elke Eltze, et al.. (2019). Low Numbers of Vascular Vessels Correlate to Progression in Hormone-Naïve Prostate Carcinomas Undergoing Radical Prostatectomy. Cancers. 11(9). 1356–1356. 8 indexed citations
14.
Popęda, Marta, Tomasz Stokowy, Natalia Bednarz‐Knoll, et al.. (2019). NF-kappa B Signaling-Related Signatures Are Connected with the Mesenchymal Phenotype of Circulating Tumor Cells in Non-Metastatic Breast Cancer. Cancers. 11(12). 1961–1961. 17 indexed citations
15.
Markiewicz, Aleksandra, Jolanta Szade, Hanna Majewska, et al.. (2017). Expression of stem cell and mesenchymal markers in circulating tumor cells is associated with poor prognosis of early breast cancer patients. Annals of Oncology. 28. vii32–vii32. 1 indexed citations
16.
Łapińska‐Szumczyk, Sylwia, Anna Supernat, Hanna Majewska, et al.. (2014). HER2‐Positive Endometrial Cancer Subtype Carries Poor Prognosis. Clinical and Translational Science. 7(6). 482–488. 22 indexed citations
17.
Markiewicz, Aleksandra, Magdalena Książkiewicz, Marzena Wełnicka-Jaśkiewicz, et al.. (2014). Mesenchymal Phenotype of CTC-Enriched Blood Fraction and Lymph Node Metastasis Formation Potential. PLoS ONE. 9(4). e93901–e93901. 38 indexed citations
18.
Senkus, Elżbieta, Jolanta Szade, Anna J. Żaczek, et al.. (2013). Are bilateral breast cancers different from breast cancers coexisting with ovarian cancer? An immunohistochemical analysis aimed at intrinsic tumor phenotype. The Breast. 22(4). 425–430. 1 indexed citations
19.
Żaczek, Anna J., Aleksandra Markiewicz, Janusz Jaśkiewicz, et al.. (2010). Clinical evaluation of developed PCR-based method with hydrolysis probes for TOP2A copy number evaluation in breast cancer samples. Clinical Biochemistry. 43(10-11). 891–898. 11 indexed citations
20.
Żaczek, Anna J. & Charlotta Zetterström. (1997). Cataract surgery and pupil size in patients with diabetes mellitus. Acta Ophthalmologica Scandinavica. 75(4). 429–432. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026